Risk of Myocardial Infarction and Stroke in Newly Diagnosed Systemic Lupus Erythematosus: A General Population‐Based Study

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Arthritis care & research

• Publication date

  2017-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/acr.23018PMID 28129475
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Atherosclerosis in systemic lupus erythematosus.

  2017cited by this paper
• Validity of Diagnostic Codes for Acute Stroke in Administrative Databases: A Systematic Review

  2015cited by this paper
• Overall and Cause‐Specific Mortality in Patients With Systemic Lupus Erythematosus: A Meta‐Analysis of Observational Studies

  2014cited by this paper
• Risk of deep venous thrombosis and pulmonary embolism in individuals with polymyositis and dermatomyositis: a general population-based study

  2014cited by this paper
• Prevention and management of comorbidities in SLE

  2014cited by this paper
• Increased risk of acute myocardial infarction and mortality in patients with systemic lupus erythematosus: two nationwide retrospective cohort studies.

  2014cited by this paper
• Prevention and management of co-morbidities in SLE.

  2014cited by this paper
• Selection bias in rheumatic disease research

  2014cited by this paper
• Validity of Myocardial Infarction Diagnoses in Administrative Databases: A Systematic Review

  2014cited by this paper
• Mortality and Cardiovascular Burden of Systemic Lupus Erythematosus in a US Population-based Cohort

  2014cited by this paper
• The risk of deep venous thrombosis and pulmonary embolism in giant cell arteritis: a general population-based study

  2014cited by this paper
• The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic review.

  2013cited by this paper
• Risk Factors in Cardiovascular Disease in Systemic Lupus Erythematosus

  2013cited by this paper
• Atherosclerosis in Systemic Lupus Erythematosus

  2013cited by this paper
• Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden.

  2012cited by this paper
• Increased risk of ischemic stroke in patients with systemic lupus erythematosus: a nationwide population-based study.

  2012cited by this paper
• Cardiovascular event in systemic lupus erythematosus in northern Sweden: Incidence and predictors in a 7-year follow-up study

  2012cited by this paper
• Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden

  2012cited by this paper
• Systemic lupus erythematosus and risk of cardiovascular disease Results from the Nurses’ Health Study

  2011cited by this paper
• The Accuracy of Administrative Data Diagnoses of Systemic Autoimmune Rheumatic Diseases

  2011cited by this paper
• Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study.

  2009cited by this paper
• Poor Outcomes After Acute Myocardial Infarction in Systemic Lupus Erythematosus

  2009cited by this paper
• Annual incidence and standardized incidence ratio of cerebrovascular accidents in patients with systemic lupus erythematosus

  2009cited by this paper
• Purposeful selection of variables in logistic regression

  2008cited by this paper
• Patients and professionals as research partners: challenges, practicalities, and benefits.

  2006cited by this paper
• Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964-95.

  2004cited by this paper
• Prognostic factors and long-term evolution in a cohort of 133 patients with giant cell arteritis.

  2001cited by this paper
• Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus.

  2001cited by this paper
• Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus.

  1999cited by this paper
• A Proportional Hazards Model for the Subdistribution of a Competing Risk

  1999cited by this paper
• Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

  1999cited by this paper
• Sensitivity and positive predictive value of Medicare Part B physician claims for rheumatologic diagnoses and procedures.

  1997cited by this paper
• Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study.

  1997cited by this paper
• Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives.

  1993cited by this paper
• Outcome in Systemic Lupus Erythematosus: A Prospective Study of Patients from a Defined Population

  1989cited by this paper
• A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

  1987cited by this paper

• Impact of systemic lupus erythematosus on cardiovascular health in young adults

  2026cites this paper
• ‘Information is power’: A qualitative exploration of co-producing education resources about cardiovascular disease in partnership with women living with lupus

  2025cites this paper
• The Interplay Between Autoimmune Disorders Affecting the Coagulation and Platelet Systems and Their Implications for Cardiovascular Diseases: A Systematic Review

  2025cites this paper
• The Evolving Field of Cardio-Rheumatology: Global Patterns and Research Gaps, 1953-2025

  2025cites this paper
• Heterogeneous myocardial contraction detected by speckle tracking echocardiography in systemic lupus erythematosus is associated with complement protein C4: a cross-sectional study from a Swedish tertiary referral centre

  2025cites this paper
• Progression of atherosclerotic plaques over 3 years in patients with systemic lupus erythematosus is inversely associated with continuous hydroxychloroquine treatment

  2025cites this paper
• Cardiovascular magnetic resonance as an initial screening tool in individuals with SLE and chest pain

  2025cites this paper
• Cardiovascular disease risk in Korean patients with systemic lupus erythematosus compared to diabetes mellitus and the general population

  2025cites this paper
• A novel approach to cardiovascular events in patients with systemic lupus erythematosus: risk factor assessment and treatment analysis

  2025cites this paper
• Clinical significance of anti-lipoprotein lipase antibodies in Japanese patients with systemic lupus erythematosus

  2025cites this paper
• Prevalence of and risk factors for important comorbidities of systemic lupus erythematosus using data from a multicenter Chinese cohort registry: A cross-sectional study

  2025cites this paper
• Atherosclerotic cardiovascular disease in systemic lupus erythematosus: from preclinical lupus to atherosclerotic plaque erosion

  2025cites this paper
• Mortality associated with systemic lupus erythematosus combined with heart failure in the United States (1999–2020): A multiple-cause-of-death study

  2025cites this paper
• Lupus-Induced Accelerated Heart Failure in a Young African American Female: Cardiovascular and Systemic Complications of Noncompliance to Maintenance Therapy and the Social Determinants of Cardiovascular Disease

  2024influential citation
• Increased cardiovascular risk in Korean patients with systemic lupus erythematosus: a population-based cohort study

  2024cites this paper
• Emergency Revascularization for Acute Vertebral Artery Occlusion Accompanied by Systemic Lupus Erythematosus: A Case Report

  2024cites this paper
• Three-dimensional speckle tracking echocardiography for evaluation of ventricular function in patients with systemic lupus erythematosus: relationship between duration of lupus erythematosus and left ventricular dysfunction by using global longitudinal strain

  2024cites this paper
• Antiphospholipid antibodies as potential prognostic indicators of recurrent ischemic stroke.

  2024cites this paper
• Deciphering Mechanisms, Prevention Strategies, Management Plans, Medications, and Research Techniques for Strokes in Systemic Lupus Erythematosus

  2024cites this paper
• Damage in a large systemic lupus erythematosus cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER) with emphasis on the cardiovascular system: a longitudinal analysis

  2024cites this paper
• Prevalence of cardiovascular events in a population-based registry of patients with systemic lupus erythematosus

  2024cites this paper
• Cardiovascular disease risk in systemic lupus erythematous: Certainties and controversies.

  2024cites this paper
• Incidence and Prevalence of Atherosclerotic Cardiovascular Disease in Cutaneous Lupus Erythematosus.

  2024cites this paper
• Personalizing cardiovascular risk prediction for patients with systemic lupus erythematosus

  2024cites this paper
• Relationship of serum and dietary vitamin D with high cardiometabolic risk in Mexican systemic lupus erythematosus patients: A cross-sectional study

  2024cites this paper
• An update on cardiovascular disorders in systemic lupus erythematosus.

  2024cites this paper
• Evaluating the risk of ischemic stroke at a young age in patients with autoimmune inflammatory rheumatic diseases: a population-based cohort study in Taiwan

  2024cites this paper
• Ten-year follow-up investigation of stroke risk in systemic lupus erythematosus

  2023cites this paper
• Primary aldosteronism: an unsuspected culprit of hypertension in systemic lupus erythematosus?

  2023cites this paper
• Systemic lupus erythematosus and damage: What has changed over the past 20 years?

  2023cites this paper
• [Management of cardiovascular comorbidities in immune-mediated inflammatory diseases].

  2023cites this paper
• Myocardial fibrosis associates with lupus anticoagulant in patients with systemic lupus erythematosus

  2023cites this paper
• Atherosclerosis in Systemic Lupus Erythematosus

  2023cites this paper
• Lupus Eritematoso Sistémico: generalidades sobre su fisiopatología, clínica, abordaje diagnóstico y terapéutico

  2023cites this paper
• Antimalarial Adherence and Risk of Cardiovascular Events in Patients With Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Population‐Based Study

  2023cites this paper
• Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society

  2023cites this paper
• Safety profile of baricitinib in patients with systemic lupus erythematosus: an integrated analysis

  2023cites this paper
• Screening of Potential Circulating Diagnostic Biomarkers and Molecular Mechanisms of Systemic Lupus Erythematosus-Related Myocardial Infarction by Integrative Analysis

  2023influential citation
• A Woman’s Heart: Improving Uptake and Awareness of Cardiovascular Screening for Middle-Aged Populations

  2023cites this paper
• Left Ventricular Strain in Systemic Diseases

  2023cites this paper
• Factors associated with cardiovascular events in systemic lupus erythematosus in a monocentric cohort with up to 40 years of follow-up.

  2023cites this paper
• Sex-Specific Outcomes of Acute Stroke in Patients with Systemic Lupus Erythematosus: A National Inpatient Sample Study

  2023cites this paper
• Role of CD19+CD5+CD1d+ Bregs in maintaining the Th17/Treg balance in mice with systemic lupus erythematosus complicated with atherosclerosis

  2023cites this paper
• Acute myocardial infarction in a 16-year-old girl with systemic lupus erythematosus: A less understood complication

  2023cites this paper
• Nutritional, biochemical, and clinical determinants of hyperuricemia in systemic lupus erythematosus patients: Relationship with clinical and renal disease activity

  2022cites this paper
• Cardiovascular events and risk in patients with systemic lupus erythematosus: Systematic literature review and meta-analysis

  2022influential citation
• Assessing Myocardial Involvement in Systemic Lupus Erythematosus Patients without Cardiovascular Symptoms by Technetium-99m-sestamibi Myocardial Perfusion Imaging: A Correlation Study on NT-proBNP.

  2022cites this paper
• Cardiac damage in autoimmune diseases: Target organ involvement that cannot be ignored

  2022cites this paper
• Immune mechanisms associated with cardiovascular disease in systemic lupus erythematosus: A path to potential biomarkers

  2022cites this paper
• Platelet LGALS3BP as a Mediator of Myeloid Inflammation in Systemic Lupus Erythematosus

  2022cites this paper
• Cardiovascular Outcomes in Systemic Lupus Erythematosus

  2022cites this paper
• A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19

  2022cites this paper
• Left ventricular size and function in patients with systemic lupus erythematosus associate with lupus anticoagulant: An echocardiographic follow-up study.

  2022cites this paper
• Timing and Predictors of Incident Cardiovascular Disease in Systemic Lupus Erythematosus: Risk Occurs Early and Highlights Racial Disparities

  2022cites this paper
• Mechanistic insight into premature atherosclerosis and cardiovascular complications in systemic lupus erythematosus.

  2022cites this paper
• Systemic Lupus Erythematosus and Cardiovascular Disease: A Mendelian Randomization Study

  2022cites this paper
• Baseline Elevations of Leukotriene Metabolites and Altered Plasmalogens Are Prognostic Biomarkers of Plaque Progression in Systemic Lupus Erythematosus

  2022cites this paper
• Endothelial Dysfunction in Systemic Lupus Erythematosus and Systemic Sclerosis: A Common Trigger for Different Microvascular Diseases

  2022cites this paper
• Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement

  2022cites this paper
• Serum cytokine levels of systemic lupus erythematosus patients in the presence of concomitant cardiovascular diseases.

  2022cites this paper
• Non-ST-elevation myocardial infarction hiding behind myopericarditis in a patient with systemic lupus erythematosus

  2022cites this paper
• Clonal hematopoiesis of indeterminate potential and cardiovascular events in systemic lupus erythematosus (HEMATOPLUS study).

  2022cites this paper
• Cardiovascular Implications of Immune Disorders in Women

  2022cites this paper
• Systemic Lupus Erythematosus and Cardiovascular Disease

  2022influential citation
• Physical Activity and Systemic Lupus Erythematosus Among European Populations: A Two-Sample Mendelian Randomization Study

  2022cites this paper
• Risk of Arrhythmia Among New Users of Hydroxychloroquine in Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Population‐Based Study

  2022cites this paper
• Hydroxychloroquine Use and Cardiovascular Events Among Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis

  2021cites this paper
• Myocardial Infarction in Systemic Lupus Erythematosus: Incidence and Coronary Angiography Findings

  2021cites this paper
• Analysis of trends and causes of death in SLE patients over a 40-years period in a cohort of patients in the United Kingdom

  2021cites this paper
• Patients with systemic lupus erythematosus face a high risk of cardiovascular disease: A systematic review and Meta-analysis.

  2021cites this paper
• High Comorbidity Burden in Patients with SLE: Data from the Community-Based Lupus Registry of Crete

  2021cites this paper
• Type I Interferon as cardiovascular risk factor in systemic and cutaneous lupus erytheematosus: A systematic review.

  2021cites this paper
• All-cause and Cause-specific Mortality in Systemic Lupus Erythematosus: A Population-based Study.

  2021cites this paper
• Perfusion image guided mechanical thrombectomy combined with tirofiban successfully revascularize systemic lupus erythematosus related acute large vessel occlusion

  2021cites this paper
• Burden of comorbidities and medication use in childbearing women with rheumatic diseases: a nationwide population-based study

  2021cites this paper
• Accelerated atherosclerosis and cardiovascular disease in systemic lupus erythematosus

  2021cites this paper
• Distinct patterns of comorbidity prior to diagnosis of incident systemic lupus erythematosus in the Danish population.

  2021cites this paper
• PCSK9 and inflammation. Maybe a role in autoimmune diseases? Focus on rheumatoid arthritis and systemic lupus erythematosus.

  2021cites this paper
• Systematic review and meta-analysis of cardiovascular risk in rheumatological disease: Symptomatic and non-symptomatic events in rheumatoid arthritis and systemic lupus erythematosus.

  2021cites this paper
• Cardiovascular Disease in Patients With Systemic Lupus Erythematosus

  2021cites this paper
• Autoimmune Rheumatic Diseases and Vascular Function: The Concept of Autoimmune Atherosclerosis

  2021cites this paper
• Tissue injury—the biology

  2021cites this paper
• Cardiovascular disease in lupus

  2021cites this paper
• Comparative Risk of Incident Coronary Heart Disease Across Chronic Inflammatory Diseases

  2021cites this paper
• Evaluation of left ventricular systolic function in patients with systemic lupus erythematosus using ultrasonic layer-specific strain technology and its association with cardiovascular events: a long-term follow-up study

  2021cites this paper
• Cardiovascular Disease in Systemic Lupus Erythematosus

  2021cites this paper
• The Complex Role of C-Reactive Protein in Systemic Lupus Erythematosus

  2021cites this paper
• Clinical Outcomes of Acute Myocardial Infarction Hospitalizations with Systemic Lupus Erythematosus: An Analysis of Nationwide Readmissions Database.

  2021cites this paper
• Cardiac and vascular damage in systemic erythematosus lupus. Is disease activity the mediator?

  2020cites this paper
• Comparative Risks of Cardiovascular Disease Events among SLE Patients receiving Immunosuppressive Medications.

  2020cites this paper
• Human Immune Response to COVID-19 Infection and Potential Role of Chloroquine Family of Drugs

  2020cites this paper
• Socioeconomic status at diagnosis influences the incremental direct medical costs of systemic lupus erythematosus: A longitudinal population-based study.

  2020cites this paper
• Non-traditional risk factors and the risk of myocardial infarction in the young in the US population-based cohort

  2020cites this paper
• Anti-protein C antibodies and acquired protein C resistance in SLE: novel markers for thromboembolic events and disease activity?

  2020cites this paper
• Systemic lupus erythematosus; stroke and myocardial infarction risk: a systematic review and meta-analysis

  2020cites this paper
• Cutaneous lupus erythematosus and cardiovascular disease: current knowledge and insights into pathogenesis

  2020cites this paper
• Disease duration, age at diagnosis and organ damage are important factors for cardiovascular disease in SLE

  2020cites this paper
• Anti-Sm Antibody, Damage Index, and Corticosteroid Use Are Associated with Cardiac Involvement in Systemic Lupus Erythematosus: Data from a Prospective Registry Study

  2020cites this paper
• Comparative Risks of Cardiovascular Disease in Patients With Systemic Lupus Erythematosus, Diabetes Mellitus, and in General Medicaid Recipients

  2020cites this paper
• Hydroxychloroquine and Mortality Among Patients With Systemic Lupus Erythematosus in the General Population

  2020cites this paper